Genitofemoral neuralgia is an uncommon pain disorder that could be resistant to conventional treatment. A 78-year-old woman with refractory right genitofemoral neuralgia was treated with BoNT/A subcutaneous injections; the treatment was performed three times with significant pain improvement, although temporary, and without adverse events. BoNT/A may be a promising alternative intervention in the setting of genitofemoral neuralgia refractory to oral and/or topical treatment
Copyright © 2014 Harsha Shanthanna.This is an open access article distributed under the Creative Com...
MMNPInternational audienceOBJECTIVE: Botulinum toxin type A (BTX-A) has been reported to have analge...
Introduction. Trigeminal neuralgia (TN) is one of the most common neurological diseases involving th...
AbstractChronic pain indicates a type of pain that lasts over time and is accompanied by diagnostic ...
Botulinum neurotoxin (BoNT), derived from Clostridium botulinum, has been used therapeutically for f...
This article illustrates a case of persistent trigeminal neuralgia in a medically compromised 65-yea...
Neuropathic pain includes postherpetic neuralgia (PHN), painful diabetic neuropathy (PDN), and trige...
Botulinum toxin (BoNT) has been used as a treatment for excessive muscle stiffness, spasticity, and ...
Pain is a natural protective mechanism and has a warning function signaling imminent or actual tissu...
Botulinum toxin type A (BTX-A((R))) has been widely used in many clinical disorders including migrai...
Trigeminal neuralgia (TN) is a disorder characterized by severe abrupt lancinating pains, limited to...
BACKGROUND: Despite their huge epidemiological impact, primary headaches, trigeminal neuralgia and ...
Evidence is emerging for the use of botulinum neurotoxin type-A (BoNT-A) for niche indications inclu...
Therapeutic use of botulinum neurotoxins is well established and is continuously expanding. In clini...
The vulva is a particularly common locus of chronic pain with neuropathic characteristics that occur...
Copyright © 2014 Harsha Shanthanna.This is an open access article distributed under the Creative Com...
MMNPInternational audienceOBJECTIVE: Botulinum toxin type A (BTX-A) has been reported to have analge...
Introduction. Trigeminal neuralgia (TN) is one of the most common neurological diseases involving th...
AbstractChronic pain indicates a type of pain that lasts over time and is accompanied by diagnostic ...
Botulinum neurotoxin (BoNT), derived from Clostridium botulinum, has been used therapeutically for f...
This article illustrates a case of persistent trigeminal neuralgia in a medically compromised 65-yea...
Neuropathic pain includes postherpetic neuralgia (PHN), painful diabetic neuropathy (PDN), and trige...
Botulinum toxin (BoNT) has been used as a treatment for excessive muscle stiffness, spasticity, and ...
Pain is a natural protective mechanism and has a warning function signaling imminent or actual tissu...
Botulinum toxin type A (BTX-A((R))) has been widely used in many clinical disorders including migrai...
Trigeminal neuralgia (TN) is a disorder characterized by severe abrupt lancinating pains, limited to...
BACKGROUND: Despite their huge epidemiological impact, primary headaches, trigeminal neuralgia and ...
Evidence is emerging for the use of botulinum neurotoxin type-A (BoNT-A) for niche indications inclu...
Therapeutic use of botulinum neurotoxins is well established and is continuously expanding. In clini...
The vulva is a particularly common locus of chronic pain with neuropathic characteristics that occur...
Copyright © 2014 Harsha Shanthanna.This is an open access article distributed under the Creative Com...
MMNPInternational audienceOBJECTIVE: Botulinum toxin type A (BTX-A) has been reported to have analge...
Introduction. Trigeminal neuralgia (TN) is one of the most common neurological diseases involving th...